These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32937631)

  • 1. A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours.
    Exarchou K; Moore AR; Smart HL; Duckworth CA; Howes N; Pritchard DM
    Neuroendocrinology; 2021; 111(8):764-774. PubMed ID: 32937631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal neuroendocrine neoplasms with unexpectedly aggressive behaviour: Challenging the "watch and wait" approach.
    Ratnayake GM; Srirajaskanthan R; Luong T; Gnanasegaran G; Toumpanakis C
    J Neuroendocrinol; 2022 Jan; 34(1):e13067. PubMed ID: 34914146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours.
    Exarchou K; Howes N; Pritchard DM
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1247-1267. PubMed ID: 32390152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors.
    Shroff SR; Kushnir VM; Wani SB; Gupta N; Jonnalagadda SS; Murad F; Early DS; Mullady DK; Edmundowicz SA; Azar RR
    Surg Laparosc Endosc Percutan Tech; 2015 Oct; 25(5):e134-9. PubMed ID: 26271024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.
    Mekkan-Bouv Hez M; Derbey L; de Mestier L; Lorenzo D; Walter T; Perrier M; Cadiot G; Goichot B; Pracht M; Lièvre A; Coriat R; Valancot S; Guimbaud R; Carrere N; Bacoeur-Ouzillou O; Belleannée G; Smith D; Laboureau S; Hescot S; Julie C; Teissier MP; Thereaux J; Ferru A; Evrard C; Mathonnet M; Christou N
    Int J Surg; 2024 Jul; 110(7):4259-4265. PubMed ID: 38573078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
    Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
    Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence pattern and surveillance strategy for rectal neuroendocrine tumors after endoscopic resection.
    Chung HG; Goh MJ; Kim ER; Hong SN; Kim TJ; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2021 Apr; 36(4):968-973. PubMed ID: 32864790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of gastric and duodenal neuroendocrine tumors.
    Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
    World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
    World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
    Liu E; Paulson S; Gulati A; Freudman J; Grosh W; Kafer S; Wickremesinghe PC; Salem RR; Bodei L
    Oncologist; 2019 Jun; 24(6):783-790. PubMed ID: 30158287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endoscopic Resection of Sporadic Non-ampullary Duodenal Neoplasms: A Single Center Study].
    Nam YJ; Lee SH; Kim KO; Jang BI; Kim TN; Kim YJ
    Korean J Gastroenterol; 2016 Jan; 67(1):8-15. PubMed ID: 26809626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic submucosal resection using a ligation device without injection for duodenal neuroendocrine tumors.
    Oono Y; Shinmura K; Hori K; Yoda Y; Ishii G; Ikematsu H; Yano T
    Surg Endosc; 2019 Jun; 33(6):2008-2014. PubMed ID: 30604268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
    Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J
    J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
    Nießen A; Bergmann F; Hinz U; Schimmack S; Hackert T; Büchler MW; Strobel O
    Eur J Surg Oncol; 2020 Jun; 46(6):1088-1096. PubMed ID: 32088004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
    Matsumoto K; Fujimori N; Hata Y; Minoda Y; Murakami M; Teramatsu K; Takamatsu Y; Takeno A; Oono T; Ihara E; Nakata K; Nakamura M; Yamamoto T; Koga Y; Oda Y; Ito T; Ogawa Y
    Dig Dis; 2023; 41(2):316-324. PubMed ID: 35588707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
    World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.